This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted.Find sources: "Omnicell" – news · newspapers · books · scholar · JSTOR (April 2021) (Learn how and when to remove this template message) This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citations to reliable, independent, third-party sources. (April 2021) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

Omnicell, Inc.
Company typePublic company
IndustryHealthcare technology services
FoundedSeptember 1992; 31 years ago (1992-09)
FounderRandall A. Lipps
HeadquartersMountain View, California, U.S.
Key people
  • Randall A. Lipps (Chairman, President, and CEO)
  • Scott Seidelmann (Chief Commercial Officer)
  • Dan S. Johnston (Chief Legal and Administrative Officer)
  • Christine Mellon (Chief People Officer)
RevenueIncrease US$1.13 billion (2021)
Increase US$89.5 million (2021)
Increase US$77.8 million (2021)
Total assetsIncrease US$2.14 billion (2021)
Total equityIncrease US$1.15 billion (2021)
Number of employees
c. 3,800 (December 2021)
Websiteomnicell.com
Footnotes / references
[1]

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, California. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

Company history

1992–1999

Omnicell Technologies, Inc. was founded in September 1992 by Randall A. Lipps after his daughter was hospitalized at birth and he observed nurses had difficulty locating medical supplies. With the help of graduate students from Stanford University, he developed a prototype of a system that automated inventory management tasks performed manually by nurses.[2]

With Lipps as the chairman of the company, it commercially began developing automated supply cabinets in 1993. The cabinets were capable of tracking transaction data, inventory levels, expenses, and patient billing. Sales figures reached $7.7 million by the end of 1995 and increased the following year to $21.5 million. The company expanded services by developing pharmacy automation systems for dispensing medications in 1996. They expanded their product line in 1999 by acquiring the SureMed line of pharmacy cabinets from Baxter Healthcare Corp.[2]

2000–2020

By the end of the 1990s, the company had installed more than 14,000 automated dispensing cabinets in more than 1,300 healthcare facilities, and sales grew to $50 million.[2] Omnicell went public in August 2001, changing the company’s name to Omnicell, Inc.[3]

In 2002 Lipps assumed the role of CEO, replacing Sheldon D. Asher. In 2003, Omnicell acquired BCX Technology, Inc., a maker of wireless, handheld bar-code scanners that could track pharmaceutical dispensation.[2] The company further expanded with more acquisitions. Its purchase of MTS Technologies added multiple-dose medication blister cards used by retail pharmacies to encourage medication adherence. The acquisition of Aesynt Inc. added pharmacy robots for inventory management, specialized IV compounding robots to remove human error, and pharmacy data intelligence software. The acquisition of Ateb, Inc., which provided patient engagement and patient communication systems to retail pharmacies, led to the formation of the EnlivenHealth business segment in 2020.[4][5]

Acquisitions and partnerships

Finances

This section does not cite any sources. Please help improve this section by adding citations to reliable sources. Unsourced material may be challenged and removed. (April 2021) (Learn how and when to remove this template message)
Year Revenue
in mil. USD$ 		Net income
in mil. USD$ 		EBITDA
in mil. USD$ 		Total Assets
in mil. USD$ 		Total Equity
in mil. USD$ 		Price per Share
in USD$ 		Employees
2011 246 10 25 362 283 17
2012 314 16 45 442 308 15
2013 381 24 56 493 349 26
2014 441 31 71 560 390 33
2015 485 31 71 579 402 31
2016 693 1 73 935 432 34
2017 716 21 61 980 517 49 2372
2018 787 38 100 1081 680 61 2501
2019 897 61 142 1241 845 82 2698
2020 892 32 117 1825 968 120 2862
2021 1132 78 230 2142 1147 180 3800

References

  1. ^ "Omnicell, Inc. 2021 Annual Report (Form 10-K)". SEC.gov. U.S. Securities and Exchange Commission. February 25, 2021.
  2. ^ a b c d "Profile - Omnicell, Inc". www.encyclopedia.com.
  3. ^ Staff (August 7, 2001). "Omnicell IPO up 36%". CNN Money.
  4. ^ Levy, Sandra (October 2, 2020). "Omnicell acquires Pharmaceutical Strategy Group's 340B software-enabled service business". Drug Store News.
  5. ^ a b Salazar, David (November 29, 2016). "Omnicell to acquire Ateb". Drug Store News.
  6. ^ Zacks Equity Research (May 29, 2012). "Omnicell Completes MTS Acquisition". Yahoo! Finance.
  7. ^ "Omnicell, Inc. Signs Agreement with Bupa Care Homes (CFG) plc to Acquire UK-Based SurgiChem Limited". Fierce Healthcare (Press release). Omnicell. December 9, 2013.
  8. ^ "Omnicell, Inc. Closes Acquisition of Germany-based MACH4 Pharma Systems" (Press release). Omnicell. April 24, 2015 – via news.thomasnet.com.
  9. ^ "Omnicell and AVANTEC Launch Europe's Largest Deployment of Automated Medical Supply Systems" (Press release). Omnicell. October 23, 2008 – via BioSpace.
  10. ^ Demaitre, Eugene (November 23, 2015). "Omnicell Buys Automated Pharmacy Firm Aesynt for $275M". Robotics Business Review.
  11. ^ "Omnicell Acquires InPharmics" (Press release). Omnicell. April 19, 2017 – via Pharmaceutical Processing World.
  12. ^ "Omnicell Completes Acquisition of Pharmaceutical Strategy Group's Leading 340B Software-Enabled Service Business" (Press release). Omnicell. October 1, 2020 – via Business Wire.
  13. ^ "Omnicell to Partner with Guy's and St Thomas' NHS Foundation Trust, London on Development of European Technology-Enabled Intelligence Centre as Part of Expansion of Omnicell Systems" (Press release). Omnicell. January 4, 2021 – via BioSpace.

External links

Categories